Help us make better tools for you!. Read more (Published: 2017-01-12)

IMNP - Immune Pharmaceuticals Inc. Fri 13'th Jan 2017

Add to Watchlist

Buy Candidate

Score: 3.86

#1220 of 5193
Trend:
MV Long:
MV Short:
Pivot:
Volume:
MACD:
Accuracy: 81.58%
Risk: Medium
Request Prediction
We need your help. Please answer this short survey to help us improve by clicking HERE.

Stock analysis for Fri 13'th Jan 2017 (Updated daily)

Buy candidate since 2017-01-12

Gain 5.00%

Immune Pharmaceuticals Inc. Stock Analysis


Immune Pharmaceuticals Inc. gained 5.00% in the last trading day rising from, USD 0.20 to USD 0.21. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a 16.67% gain for the last 2 weeks. Volume fell in the last day by -15.61 million shares and ,in total, 7.74 million shares bought and sold for approximately USD 1.63 million. You should note that falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Trend

Immune Pharmaceuticals Inc. has broken the wide and strong falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction there will be support on the roof on the current trend broken, which is USD 0.20, a level that may pose a second chance to hit a runner. According to fan-theory USD 0.25 will be the next possible trendtop level and thereby pose a resistancelevel which may not be broken on the first attempt.

Signals

There are mixed signals in the stock today. A buy signal was issued from a pivot bottom point on Friday January 06, 2017, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Relative Strength Index (RSI)

The stock holds a RSI14 at 71 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Support & Resistance

Immune Pharmaceuticals Inc. finds support from accumulated volume at USD 0.20, USD 0.19, and USD 0.18. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 0.22, USD 0.24 and USD 0.26.

The stock is about to test the resistance from accumulated volume at USD 0.22 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day the stock moved USD 0.03 between high and low, and this equals 14.58%. For the last week, the stock has had a daily average volatility of 14.34%.

The stock is extremely overbought on RSI14 (71). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stoploss: USD 0.20 (-4.76%) ( based on support and risk)

Evaluation

Several short term signals are positive and the break up from the strong falling indicates a possible shift of trend. We believe prices around the breaking point to be particulary good levels but also believe that current level will hold a possible good buy level for the short term.

Buy Candidate


Want to be one step ahead of others?

Subscribe Now!

Click for pro features list

Last donation


lgillies

Do you find our website useful too?
Help us improve by making a small donation.

Want to be one step ahead of others?

Subscribe Now!

Click for pro features list

Chart Explanation

Build Your Watchlist

Add IMNP My Watchlist

Weekly Trading Secrets

Recommenended
book of the week

5193
Companies analyzed today